Aortic stenosis and obstructive hypertrophic cardiomyopathy are common conditions. When both are present in the same patient, the management can be challenging. We report what we believe to be the first time a cardiac myosin inhibitor has been used before transcutaneous aortic valve replacement.
Download full-text PDF |
Source |
|---|---|
| http://www.ncbi.nlm.nih.gov/pmc/articles/PMC11137528 | PMC |
| http://dx.doi.org/10.1016/j.jaccas.2024.102381 | DOI Listing |
Publication Analysis
Top Keywords
cardiac myosin
8
myosin inhibition
4
inhibition treatment
4
treatment lvot
4
lvot obstruction
4
obstruction patient
4
patient severe
4
severe aortic
4
aortic stenosis
4
stenosis obstructive
4
Similar Publications
Want AI Summaries of new PubMed Abstracts delivered to your In-box?
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!